Niels Abildgaard

20032019
If you made any changes in Pure these will be visible here soon.

Personal profile

Curriculum

Education
1983                       MD, University of Aarhus, Denmark
1985                       Authorisation to practice Medicine in Denmark
1998                       Specialist degree in Internal Medicine
1999                       Specialist degree in Haematology
2005                       "Good Clinical Practice" course for investigators, Aarhus University

Academic dissertations and Degrees
2006                        Doctor Medicinae (dr.med.) thesis, Faculty of Health Sciences, University of Aarhus, Denmark:
                                "The bone disease in multiple myeloma: pathophysiologic, clinical, and prognostic aspects".

Clinical Appointments
1983-1991                Resident and Senior House Officer, Aarhus University Hospital and Aalborg Hospital, Denmark
1992-1996                Senior House Officer, Depts. of Internal Medicine and Haematology, Aarhus University Hospital, Denmark
1997-2002                Senior Registrar, Dept. of Haematology, Odense University Hospital, Odense, Denmark
2002-2003                Senior Registrar, Dept. of Haematology, Rigshospitalet, Copenhagen, Denmark
2004-                        Consultant, Dept. of Haematology, Odense University Hospital, Denmark

Academic Appointments and Fellowships
1993-1994                Research Fellow at University of Aarhus
2000-2004                Senior Lecturer in Internal Medicine, Faculty of Health Sciences, University of Aarhus, Denmark
2006-2010                Senior Lecturer in Haematology, Faculty of Medical Sciences, University of Southern Denmark
2007-                        Head of the Clinical Research Unit, Department of Haematology, Odense University Hospital
2010-                        Professor of Haematology, Faculty of Medical Sciences, University of Southern Denmark 

 

 

 

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Plasma Cells Medicine & Life Sciences
Serum Medicine & Life Sciences
Melphalan Medicine & Life Sciences
Hepatocyte Growth Factor Medicine & Life Sciences
Denmark Medicine & Life Sciences
Quality of Life Medicine & Life Sciences
Alleles Medicine & Life Sciences
Interleukin-6 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

Clarithromycin added to bortezomib‐cyclophosphamide‐dexamethasone impairs health‐related quality of life in multiple myeloma patients

Nielsen, L. K., Klausen, T. W., Jarden, M., Frederiksen, H., Vangsted, A. J., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, C. L., Abildgaard, N. & Gregersen, H., Jan 2019, In : European Journal of Haematology. 102, 1, p. 70-78

Research output: Contribution to journalJournal articleResearchpeer-review

Clarithromycin
Quality of Life
Bortezomib
Placebos

Methodological aspects of health-related quality of life measurement and analysis in patients with multiple myeloma

Kongsgaard Nielsen, L., Abildgaard, N., Jarden, M. E. & Klausen, T. W., Jan 2019, In : British Journal of Haematology.

Research output: Contribution to journalReviewResearchpeer-review

A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

Gregersen, H., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, N. F., Nielsen, L. K., Andersen, C. L., Klausen, T. W., Vangsted, A. J. & Abildgaard, N., 13 Aug 2018, In : Experimental Hematology & Oncology. 7, 8 p., 18.

Research output: Contribution to journalJournal articleResearchpeer-review

Melphalan
Clarithromycin
Placebos
Neutropenic Enterocolitis
Intestinal Pseudo-Obstruction

Assessment of bone turnover in multiple myeloma patients before and after treatment

Zadeh, M. Z., Raynor, W., Østergaard, B., Taghvaei, R., Acosta-Montenegro, O., Seraj, S. M., Saboury, B., Al-Zaghal, A., Yellanki, D., Ayubcha, C., Werner, T., Abildgaard, N., Zhuang, H., Høilund-Carlsen, P. F. & Alavi, A., 2018, In : Journal of Nuclear Medicine. 59, Suppl. 1, p. 1429 1 p.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Activities 2002 2018

European Hematology Association 23rd congress EHA 2018

Niels Abildgaard (Participant)
14 Jun 201817 Jun 2018

Activity: Attending an eventConference organisation or participation

DMSG Plenummøde

Niels Abildgaard (Chairman)
23 May 2018

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

Role of ImiDs in Multiple Myeloma

Niels Abildgaard (Guest lecturer)
7 Feb 2018

Activity: Talks and presentationsTalks and presentations in private or public companies

Intenational Myelom Working Group Summit

Niels Abildgaard (Participant)
11 Jun 201812 Jun 2018

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

Helbredsrelateret livskvalitet hos myelomatosepatienter ved tillæg af clarithromycin til VCD induktionsbehandling før autolog knoglemarvstransplantation; resultater fra CLAIM studiet

Lene Kongsgaard Nielsen (Guest lecturer), TW Klausen (Guest lecturer), Ida Bruun Kristensen (Guest lecturer), Niels Abildgaard (Guest lecturer), Henrik Gregersen (Guest lecturer)
9 Mar 2018

Activity: Talks and presentationsConference presentations

Press / Media

Nyt center vil sætte fokus på livskvalitet i forskningen

Niels Abildgaard

25/01/2018

1 media contribution

Press/Media: Press / Media

Genmab-partner på jagt efter kur med kinesisk milliard-indkøb

Niels Abildgaard

23/12/2017

1 media contribution

Press/Media: Press / Media

Prizes

Formand for Nordic Myeloma Study Group

Niels Abildgaard (Recipient), 1 Dec 2012

Prize: Prizes, scholarships, distinctions